Kidney and cardiovascular effectiveness of empagliflozin compared to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
Edmonston D, Mulder H, Lydon E, et al.
Am J Cardiol. Pub. Online 17 Apr 2024.
Leggi
Edmonston D, Mulder H, Lydon E, et al.
Am J Cardiol. Pub. Online 17 Apr 2024.
Leggi
Wallner M, Biber ME, Stolfo D, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. Online 17 Apr 2024.
Leggi
Zeitler P, Galindo RJ, Davies MJ, et al.
Diabetes Care. Pub. Online 19 Apr 2024.
Leggi
Hu Y, Li X, Wang X, et al.
Diabetes Obes Metab. Pub. Online 15 Apr 2024.
Leggi
Ajjan RA, Battelino T, Cos X, et al.
Nat Rev Endocrinol. Pub. Online 8 Apr 2024.
Leggi
Brouwers B, Rao G, Tang Y, et al.
Diabetes Res Clin Pract. Pub. Online 16 Apr 2024.
Leggi
Deng S, Hu X, Zhang X
Diabetes Obes Metab. Pub. Online 15 Apr 2024.
Leggi
Jacobsen LM, Cuthbertson D, Bundy BN, et al.
Diabetes Care. Pub. Online 15 Apr 2024.
Leggi
Irlik K, Aldosari H, Hendel M, et al.
Diabetes Obes Metab. Pub. Online 11 Apr 2024.
Leggi
Grando Alves G, Cunha L, Henkes Machado R, et al.
Diabetes Obes Metab. Pub. Online 11 Apr 2024.
Leggi